259 related articles for article (PubMed ID: 27267737)
1. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
Szarvas T; Módos O; Niedworok C; Reis H; Szendröi A; Szász MA; Nyirády P
Urol Oncol; 2016 Sep; 34(9):388-98. PubMed ID: 27267737
[TBL] [Abstract][Full Text] [Related]
2. Options for diagnosis and treatment of urachal carcinoma.
Zhang J; Wu J
Asia Pac J Clin Oncol; 2013 Jun; 9(2):117-22. PubMed ID: 23046343
[TBL] [Abstract][Full Text] [Related]
3. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Módos O; Reis H; Niedworok C; Rübben H; Szendröi A; Szász MA; Tímár J; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollósi P; Nyirády P; Szarvas T
Oncotarget; 2016 Jun; 7(26):39293-39301. PubMed ID: 27283768
[TBL] [Abstract][Full Text] [Related]
4. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies.
Olah C; Kubik A; Mátrai P; Engh MA; Barna V; Hegyi P; Reis H; Nyirády P; Szarvas T
Urol Oncol; 2024 Jul; 42(7):221.e1-221.e7. PubMed ID: 38627107
[TBL] [Abstract][Full Text] [Related]
6. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.
Ashley RA; Inman BA; Sebo TJ; Leibovich BC; Blute ML; Kwon ED; Zincke H
Cancer; 2006 Aug; 107(4):712-20. PubMed ID: 16826585
[TBL] [Abstract][Full Text] [Related]
7. Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma.
Zheng Y; Peng H; Hu X; Ou Y; Wang D; Wang H; Ren S
Front Pharmacol; 2023; 14():1199395. PubMed ID: 37324454
[No Abstract] [Full Text] [Related]
8. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
[TBL] [Abstract][Full Text] [Related]
9. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
Shao G; Xu C; Liu J; Li X; Li L; Li X; Zhang X; Fan Y; Zhou L
Urol Int; 2022; 106(2):199-208. PubMed ID: 34515250
[TBL] [Abstract][Full Text] [Related]
10. Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
Limonnik V; Samiei A; Abel S; Wegner RE; Vemana G; Mao SS
Cancer Med; 2023 Feb; 12(3):2752-2760. PubMed ID: 36069175
[TBL] [Abstract][Full Text] [Related]
11. Value of MRI in evaluating urachal carcinoma: A single center retrospective study.
Das JP; Woo S; Ghafoor S; Andrieu PIC; Ulaner GA; Donahue TF; Goh AC; Vargas HA
Urol Oncol; 2022 Jul; 40(7):345.e9-345.e17. PubMed ID: 35351368
[TBL] [Abstract][Full Text] [Related]
12. Urachal cancer-current concepts of a rare cancer.
Reis H; Szarvas T
Pathologe; 2019 Jun; 40(Suppl 1):31-39. PubMed ID: 30895340
[TBL] [Abstract][Full Text] [Related]
13. [Current diagnostic and treatment strategies for urachal cancer].
Módos O; Váradi M; Dér B; Keszthelyi A; Szűcs M; Reis H; Nyirády P; Szarvas T
Orv Hetil; 2023 Apr; 164(16):602-609. PubMed ID: 37087728
[TBL] [Abstract][Full Text] [Related]
14. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
16. [Urachal cancers].
Peugniez C; Ghoneim T; Leroy X; Amela E; Fantoni JC; Culine S; Villers A; Adenis A
Bull Cancer; 2013 May; 100(5):509-17. PubMed ID: 23501769
[TBL] [Abstract][Full Text] [Related]
17. Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group.
Guerin M; Miran C; Colomba E; Cabart M; Herrmann T; Pericart S; Maillet D; Neuzillet Y; Deleuze A; Coquan E; Laramas M; Thibault C; Abbar B; Mesnard B; Borchiellini D; Dumont C; Boughalem E; Deville JL; Cancel M; Saldana C; Khalil A; Baciarello G; Flechon A; Walz J; Gravis G
Front Oncol; 2023; 13():1110003. PubMed ID: 36741023
[TBL] [Abstract][Full Text] [Related]
18. Preoperative accuracy of diagnostic evaluation of urachal carcinoma.
Ke C; Hu Z; Yang C
Cancer Med; 2023 Apr; 12(8):9106-9115. PubMed ID: 36734315
[TBL] [Abstract][Full Text] [Related]
19. [A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
Sekita N; Fujimura M; Arai H; Shibata N; Nishikawa R; Sugano I; Mikami K
Hinyokika Kiyo; 2010 Aug; 56(8):447-51. PubMed ID: 20808064
[TBL] [Abstract][Full Text] [Related]
20. Urachal carcinoma: the role of magnetic resonance imaging.
Rafal RB; Markisz JA
Urol Radiol; 1991; 12(4):184-7. PubMed ID: 1645893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
